Nucleoporins interact with a chromatin network impinging on MYC enhancers. To construct maps of chromatin networks and determine how these relate to NUP153 occupancy, we combined reads generated by Nodewalk 31 and genome-wide NUP153 binding 24 analyses. The Nodewalk technique converts ligated ('3 C') chromatin DNA fragments, reflecting physical proximities between distal regions in the living cell, into corresponding chimeric RNA sequences (Extended Data Fig. 1a -i). Oligonucleotide sequences (baits) were annealed close to restriction enzyme sites flanking
T he mammalian cell nucleus displays extensive functional and structural complexity to effectuate lineage-specific gene expression patterns [1] [2] [3] [4] [5] . This is exemplified by the juxtaposition of large constitutive heterochromatic structures and developmentally repressed domains with the nuclear lamina in most somatic cells [6] [7] [8] [9] [10] [11] [12] [13] [14] . Such lamina-associated domains (LADs) are enriched in the repressive chromatin mark H3K9me2 and overlap with domains termed large organized chromatin K9 modifications (LOCKs) [14] [15] [16] spatially separating inactive from active chromatin regions 2 . Such structural and repressive features can be directly influenced by the extracellular environment, as illustrated by the TGFβ-induced loss of H3K9me2 marks at LOCKs 17 . A major question is how the nuclear architecture regulates gene expression in response to the cellular environment and how this process can be dysregulated in cancer 1, 18 .
The principle of gene gating, proposed more than 30 years ago 19 , posits that inducible genes can be juxtaposed with nuclear pores, which facilitates their re-activation and rapid nuclear export on repeated stimuli 20, 21 . The association of nucleoporins with chromatin might constitute an epigenetic memory underlying this process both in yeast 6 and in flies 22 . However, these principles are much less clear in human cells. Although it has been observed that some nucleoporins, that is NUP98/NUP153, can directly interact with active regions, genome-wide analyses showed that these sites are enriched in long-range-acting enhancers in human cells 23,24a feature not present in yeast 25 . Moreover, the prominent presence of nucleoporins in the nucleoplasm 6, 7 blurs functional links to the nuclear pores in mammals. The vastly disparate volumes of both the genomes and nuclei in humans and yeast 26 further compound such comparisons. Nonetheless, altogether the data 23, 24 suggest that the gating principle also exists in human cells to potentially influence the kinetics of nuclear messenger RNA export.
We document here that MYC is tethered to the nuclear pore specifically in cancer cells and that this feature increases its expression post-transcriptionally. A pathologically active MYC gene can drive an abnormally rapid cell cycle 27 to dysregulate cell proliferation in a wide range of cancers 1 . This process is facilitated by the selection of large enhancer regions, called super-enhancers, that can extend over several hundred kilobases and act over large distances, during cancer evolution 28 . Such oncogenic super-enhancers (OSEs) robustly increase the expression of target genes, such as MYC, by interdigitating different signaling pathways 29 . We document that the proximity of the OSE to both the nuclear periphery or pore and the active MYC alleles correlated with an increased nuclear export rate of MYC mRNAs in colon cancer cells. Computer modeling confirmed that the removal of MYC transcripts from the nuclear degradation system explains the difference in cytoplasmic MYC mRNA levels between colon cancer cells (HCT-116) and normal colon epithelial cells (HCECs). As this feature is antagonized by the disassembly of the β-catenin-TCF4 complex 30 , WNT signaling emerges as a key pathway in establishing an OSE-mediated gene gating function in colon cancer cells.
MYC and a selected set of enhancers, and this was followed by reverse transcription, with the resulting complementary DNAs subjected to high-throughput sequencing (Extended Data Figs. 1-3 ). Since the sequences generated by the different baits ( Supplementary  Table 1 ) converged on common regions, the reads could be constructed into networks 32 impinging on human MYC 31 (Extended Data Fig. 2 ). Using the K core value strategy 33 , we next determined the connectivity of the network nodes and their relationship to the presence of NUP153 (Supplementary Table 1 and Extended Data Figs. 2,3) 24 . Many of the most highly connected enhancer regions within the two topologically associating domains (TADs) flanking MYC in the networks generated from HCT-116 cells and HCECs were enriched in NUP153 binding (Extended Data Figs. 1h and 3a,b). By contrast, NUP153 only scarcely bound to constitutive and poorly connected peripheral heterochromatin (cLADs 12 ) flanking MYC (Extended Data Fig. 3c,d) . cLADs therefore probably represent bystander nodes proximal to MYC when this region is juxtaposed with the nuclear periphery or pores. Despite little or no occurrence of NUP133 at the MYC promoter, it displayed a cancer-cell-specific, broad occupancy within the OSE region showing the highest degree of interaction with MYC in HCT-116 cells 31 (Supplementary Table 1 and Fig. 1b ). Therefore, the binding of both NUP153 and NUP133 (part of the nuclear cage or ring structures 34 ) to the OSE, with MYC interacting primarily with NUP153 (ref. 23 ) (Extended Data Fig. 3b and Supplementary Table 1 ), indicates a division of labor between the OSE and MYC at the nuclear pore ( Fig. 1c ).
NUP133-super-enhancer proximities are dynamic. To determine the potential for interaction between NUP133 and the OSE in relation to the nuclear architecture, we used the chromatin in situ proximity (ChrISP) technique 35, 36 . This method has previously quantitatively identified proximity between DNA sequences and the H3K9me2 mark within a single locus in situ 12 . Briefly, it translates the proximity between two epitopes, here represented by NUP133 and digoxygenin (DIG)-labeled DNA fluorescence in situ hybridization (FISH) probes, into a fluorescent signal when they are separated by less than 16 nm (refs. 35, 36 ) (Extended Data Fig. 4 ). Its advantages over other microscopic techniques include high resolution (down to 10 nm) in all three dimensions, while enabling the quantitation of such proximities 35, 36 . With a biotintyramide amplification protocol to increase the representation of NUP133 epitopes, specific ChrISP signals were generated between NUP133 and the OSE (Fig. 1d ), the region with the highest frequency of interaction (ligation events) with MYC 31 (Extended Data Figs. 1-3 and Supplementary Table 1 ). The resulting NUP133-OSE signals were prominent in HCT-116 cells with little or no signal between NUP133 and the region corresponding to OSE in HCECs ( Fig. 1e,f) . The stronger OSE-NUP133 ChrISP signals at the lamina of HCT-116 cells (with 73% of all alleles within 0.3 μm of the periphery being positive ( Fig. 1g,h) ) indicates a transient anchoring of the OSE to nuclear pores. The intranuclear presence of a significant fraction of NUP133-OSE proximities concurs with the relatively prominent intranuclear presence of NUP133 (ref. 37 ). Importantly, comparable ChrISP signals could not be detected between the MYC probe ( Fig. 1e ) and NUP133 ( Fig. 1g,h) , supporting the chromatin immunoprecipitation (ChIP) results ( Fig. 1b ) and the model shown in Fig. 1c .
MYC-enhancer proximities reflect the nuclear architecture.
To examine how NUP133 occupancy relates to the OSE-MYC proximities, we performed three-dimensional (3D) DNA FISH analysis using 8-10 kb DNA FISH probes specific for either the OSE or MYC (Fig. 2a ). After hybridization to formaldehyde-fixed cells and visualization using specific antibodies, we documented that the OSE region is generally closer to the periphery than MYC in HCT-116 cells (Fig. 2b,c ), but not in HCECs (Fig. 2b ). Next, we assessed the dynamics of this polarity by comparing the distances between the nuclear periphery or nuclear pores and the OSE ('a') or MYC ('b'): the subtraction of value a from value b generated a value 'c' , which is positive when the OSE is closer to the periphery or nuclear pores and negative when MYC is closer to the periphery (Fig. 2d ). This strategy indicated that MYC trails OSE when it is less than 1 μm from the nuclear periphery ( Fig. 2e ). Importantly, the physical distance between the OSE and MYC was reduced in a manner directly proportional to their proximity to the lamina in both HCT-116 cells ( Fig. 2e ) and HCECs (Extended Data Fig. 5a ).
To validate this observation with a higher precision, we used the ChrISP technique between DNA FISH probes ( Fig. 2a ) labeled with biotin or DIG aiming to determine the proximity between the OSE and MYC regions in relation to the nuclear periphery or pore (Fig. 2f ). The results, represented by the proportion of alleles displaying a positive ChrISP signal, demonstrate that a significant fraction of MYC alleles was physically juxtaposed with OSE in HCT-116 cells compared to the negative site ( Fig. 2g and Extended Data Fig. 5b ). As MYC stochastically interacts with a range of enhancer elements equally distributed in both of its flanking TADs 31 (Extended Data Fig. 2 ), we examined whether an enhancer more proximal to MYC would also show increased potential for interaction with MYC at the nuclear periphery or pore. We selected an enhancer region at the probe D position 38 (EnhD, Extended Data Fig. 3a ), as it does not bind either NUP153 (Extended Data Fig. 3b ) or NUP133 (not shown). The results showed that the proximity between MYC and the EnhD generated significant ChrISP signals exceeding those of the OSE-MYC combination (Fig. 2g ). Next, we compared the percentage distribution of the OSE-MYC and EnhD-MYC signals in relation to the nuclear architecture using the data from Fig. 2g and Extended Data Fig. 5b ,c. This analysis showed that the OSE-MYC but not the EnhD-MYC proximities peak at the nuclear periphery ( Fig. 2h ), suggesting that the EnhD region is excluded from the OSE-MYC loop when this is tethered to the pore (Fig. 2i ).
To assess whether the proximity of these enhancers to MYC could be linked to ongoing transcription, we performed RNA FISH analyses using probes specific for intron 1 or the entire MYC gene to score for both unspliced and spliced transcripts. Sequential FISH analyses were performed by first using a combination of RNA FISH probes followed by denaturation and then DNA FISH to localize the MYC locus in identical areas ( Fig. 2j ). Following quantification, the RNA FISH data (Extended Data Fig. 5b ,c) were translated into binary signals (that is, active or inactive MYC alleles), which were binned in 0.2 μm windows in relation to the nuclear periphery. When comparing the ratios between the intron 1 probe and the probe representing the entire MYC gene (Fig. 2k ), a biphasic pattern emerged with two dominant populations of transcriptionally active MYC alleles: one more proximal (0.3-0.7 μm) and another more distal (1.1-1.3 μm) to the nuclear periphery ( Fig. 2l ). Intriguingly, although the distribution of ChrISP signals generated by the OSE-MYC or EnhD-MYC probe combinations displayed a similar biphasic pattern ( Fig. 2h ), the EnhD-MYC ChrISP signals broadly overlapped with the intron 1 RNA FISH signals. Conversely, the OSE-MYC ChrISP signal overlapped with MYC alleles harboring primarily processed mRNAs when juxtaposed with the nuclear periphery ( Fig. 2h ,k,l). Importantly, the number of alleles that were within 0.7 μm of the nuclear periphery or pore frequently exceeded one per cell ( Fig. 2m ), indicating a continuous flux of MYC alleles in relation to the nuclear periphery.
Post-transcriptional regulation of MYC expression. Next, we compared the levels of MYC transcripts in total RNA in relation to ongoing transcription in both HCT-116 cells and HCECs by quantitative polymerase chain reaction with reverse transcription (qRT-PCR) analyses. A 15-min pulse of ethynyl uridine labeling identified nascent nuclear transcripts. Although the average steady-state level of MYC transcripts was several-fold higher in HCT-116 cells than in HCECs, the average level of newly synthesized, nascent transcripts paradoxically seemed to be lower in HCT-116 cells than in HCECs (Fig. 3a ). To assess whether the difference in cytoplasmic and nuclear levels of newly synthesized MYC transcripts depended on a higher rate of nuclear MYC mRNA export in HCT-116 cells, we subjected HCT-116 cells and HCECs to 5-ethynyl uridine pulsechase experiments. The nuclear export rate of MYC transcripts was subsequently determined by qRT-PCR analyses of newly synthesized MYC mRNAs purified from the nuclear and cytoplasmic fractions (Fig. 3b ). The results show that the ratio between the pulse-chased cytoplasmic or nuclear MYC transcripts was on average fivefold higher in HCT-116 cells than in HCECs ( Fig. 3c ). Based on the combined data derived from HCT-116 cells and HCECs, there seems to be a direct relationship between the ability of the OSE to anchor MYC to the nuclear pore and the higher nuclear export rate to increase levels of cytoplasmic MYC transcripts, specifically in colon cancer cells.
To rule out trivial explanations, we first assessed whether MYC transcripts were more stable in HCT-116 cells than in HCECs. Using actinomycin D to block transcription followed by monitoring the mRNA decay in total RNA preparations, we could not detect any discernible difference in the overall MYC mRNA decay between HCT-116 cells and HCECs ( Fig. 3d , left panel). Reasoning that a higher mRNA stability in the cytoplasm compared to the nucleus 39 could explain why the OSE-mediated increased export rate is paralleled by increased MYC mRNA accumulation, we measured mRNA stability in the nuclear and cytoplasmic fractions after blocking transcription. Figure 3d shows that, following addition of actinomycin D, which inhibits transcriptional elongation, MYC transcripts containing exon 2 displayed a more than threefold shorter half-life in the nucleus than the cytoplasmic half-life in both HCT-116 cells and HCECs. To assess whether the ongoing nuclear export of MYC transcripts in HCT-116 cells significantly affected the measured half-life of MYC mRNAs, we administered leptomycin B, which inhibits the export of nuclear products 40 . Figure 3e shows that the rate of decay of nuclear MYC transcripts was affected only marginally, if at all, by this treatment in HCT-116 cells.
To determine the precision in our data, we used the information from Fig. 3a-d The results showed that the simulated data followed the observed ratios of the steady-state total MYC mRNA levels of HCT-116 cells and HCECs very closely (observation 1, Fig. 3f ). The entire time window required to generate the experimentally observed difference in MYC mRNA accumulation between HCT-116 cells and HCECs probably needs to encompass or extend beyond the nuclear and cytoplasmic half-life rates of MYC mRNAs to attain steady-state levels (the average half-lives of the exon 2-containing MYC transcripts within the nuclear and cytoplasmic fractions were determined to be 24.6 min and 85.3 min, respectively, in HCT-116 cells and 22.5 and 76.4 min, respectively, in HCECs; Fig. 3d ). This deduction is reinforced by the observation 2 data point ( Fig. 3f ), which represents a newly synthesized and exported cytoplasmic MYC mRNA population identified by a 30 min pulse of ethynyl uridine labeling followed by a 60 min chase (right-hand panel, Fig. 3a ). As the nuclear and cytoplasmic decay rates of MYC transcripts are very similar in HCT-116 cells and HCECs, we argue that the difference in cytoplasmic MYC mRNA levels between these cell populations depends on the cancer-cell-specific tethering of MYC to the nuclear pore, enabling MYC mRNAs to escape from the more rapid decay kinetics in the nucleus. 30 AHCTF1 regulates the super-enhancer-mediated gene gating process. To identify the factor (or factors) involved in the OSEmediated gene gating process we focused on the observation that a nuclear pore precursor NUP107 sub-complex, including NUP133, mediated the transport of a target plasmid DNA molecule from an intranuclear position to the nuclear pores 37 . Rather than targeting individual nucleoporins, we targeted AHCTF1 ( Fig. 4a ), earlier identified as the central factor mediating the recruitment of the entire NUP107 sub-complex to chromatin 42 . Figure 4b shows that the downregulation of AHCTF1 expression indeed led to a significant reduction in the rate of nuclear export of MYC transcripts. Importantly, this result was not accompanied by a significant change in the overall transcriptional rate of MYC (Fig. 4c ). Moreover, by combining both ChIP ( Fig. 4d ) and ChrISP analyses ( Fig. 4e,f) , we observed that the relative loss of AHCTF1 abrogated the formation of OSE-NUP133 interactions (Fig. 4e ). However, it did not interfere with the overall distribution of the OSE-MYC complexes in relation to the nuclear periphery or pore ( Fig. 4g ). Altogether, these data suggest that AHCTF1 is required to anchor the OSE to nuclear pores, but that other principles generate the polarized distribution of the OSE-MYC complexes in relation to the nuclear periphery or pore. β-catenin mediates super-enhancer anchoring to the nuclear pore and the nuclear export rate of MYC transcripts. To better understand the mechanism (or mechanisms) regulating the function of OSE in mediating gene gating, we exploited the observation that WNT signaling converges on TCF4-binding sites at enhancers directing MYC expression 29, 43, 44 in HCT-116 cells 44 . These cells not only display a WNT3a autocrine loop 45 but also express a wide range of WNT ligands promoting both canonical and non-canonical WNT signaling 46 . We targeted the canonical pathway using the drug BC21, which specifically interferes with the formation of β-catenin-TCF4 complexes 30 . In situ proximity ligation assays (ISPLAs) 12 confirmed that BC21 not only antagonized the proximity between nuclear β-catenin and TCF4, but also reduced the proximities between β-catenin and AHCTF1, and between TCF4 and AHCTF1, in HCT-116 cells ( Fig. 5a and Extended Data Fig. 6 ). Moreover, co-immunoprecipitation analyses between AHCTF1 and TCF4, and between AHCTF1 and β-catenin, verified the presence of both of these complexes and demonstrated that the AHCTF1-TCF4 interaction, but not that of AHCTF1-β-catenin, is sensitive to BC21 treatment (Fig. 5b,c) . The AHCTF1-TCF4 complex formation is therefore likely to be indirect and mediated by β-catenin. To examine whether this complex formation could be linked to the anchoring of the OSE to the nuclear periphery or pore, we performed ChrISP analyses between NUP133, which is recruited to chromatin via AHCTF1, and the OSE. Figure 5d ,e documents that BC21 treatment indeed suppressed the potential for interaction between NUP133 and the OSE as well as the apparent anchoring of the OSE to the nuclear pore.
To gain more functional insight into the direct physical interactions between AHCTF1, β-catenin and the OSE, we focused on one prominent TCF4-binding site ( Fig. 5f , WRE520 (ref. 43 )). ChIP analyses showed that AHCTF1 bound to this region several-fold more efficiently than to the MYC promoter region in HCT-116 cells ( Fig. 5g ). This is in line with the markedly lower binding of NUP133 to the MYC promoter than to the OSE (Fig. 1b,c) . Moreover, BC21 treatment significantly reduced the presence of β-catenin, AHCTF1 and NUP133 at this TCF4-binding site (Fig. 5h ). We therefore propose that the recruitment of AHCTF1, and hence nucleoporins, to the OSE is mediated by β-catenin for this TCF4-binding site (Fig. 5i ). Accordingly, BC21 treatment decreased both the export rate of newly synthesized MYC transcripts to the cytoplasm in HCT-116 cells and total cytoplasmic MYC mRNA levels to similar extents (Fig. 5j) . These data support the interpretation that β-catenin functionally regulates the gating of MYC. Importantly, under the conditions used here, BC21 did not confer any significant effect on MYC transcription (Fig. 5j) . Altogether, the data indicate that β-catenin, and by inference canonical WNT signaling, regulates the cytoplasmic levels of MYC mRNA post-transcriptionally by enabling the OSE-mediated gating of transcriptionally active MYC alleles to the nuclear pore ( Fig. 6 ).
Discussion
We have here provided insights into how a signaling pathway functions in combination with the nuclear architecture to dysregulate oncogene expression. Our results describe the transient anchoring of an oncogenic super-enhancer to the nuclear pore, or to its immediate proximity, specifically in cancer cells. Since the proximity of MYC and the OSE peaks at the nuclear periphery or pore, we argue that the OSE recruits the transcriptionally active MYC allele to the nuclear pore. Importantly, this process enables the efficient nuclear export of MYC transcripts and their escape from the several-fold more efficient degradation kinetics in the nucleus. Despite similarities in the transcriptional level and nuclear as well as cytoplasmic degradation rates of MYC mRNAs between HCECs and HCT-116 cells, HCECs displayed a significantly lower MYC mRNA nuclear export rate. This feature probably reflects an inability of the region corresponding to the OSE to anchor to the nuclear pore. Finally, computer simulations showed that the increased export kinetics in cancer cells (which probably reflect the sum of mRNA decay kinetics, the anchoring of the transcriptionally active MYC allele to the nuclear pore and the export process itself) explain the greater cytoplasmic MYC mRNA levels in HCT-116 cells than HCECs.
The biphasic distribution of the transcriptionally active MYC alleles in relation to the nuclear periphery or pore with a higher proportion of partly or completely processed transcripts at the periphery suggests that the processing of the MYC transcripts involves the dynamic movements of their templates. Although only about Fig. 1a ). The y axis shows the recovery of normalized control samples. The bars represent the mean value ± s.d. of three independent experiments (P values: two-sided, unpaired Student's t-test). e, Quantitation of ChrISP signal between NUP133 and a region within the OSE in control (siRNA against GFP mRNA) and cells in which AHCTF1 was knocked down. The results are based on two independent experiments (the alleles counted were 238 for the siGFP and 165 for the siAHCTF1 samples; P value: unpaired, two-sided Student's t-test). f, ChrISP assays detecting proximity between NUP133 and the OSE in relation to the distance to the nuclear periphery in the presence or absence of AHCTF1 expression. The difference in the distribution of the signals between the siGFP and siAHCTF1 samples (the alleles counted were 130 for the siGFP and 202 for the siAHCTF1 samples, representing the sum of two independent experiments) is statistically significant (P < 2.2 × 10 −16 , two-sided Fisher's exact test). g, 3D DNA FISH assays detecting the sub-nuclear localization of the OSE and the MYC gene with respect to the nuclear periphery in the presence or absence of AHCTF1 expression (c values calculated as in Fig. 2d , 510 alleles were counted in total with 44 and 49, and 46 and 57, data points marked in the left and right panels, respectively, used to generate the P values by two-sided Kolmogorov-Smirnov test). qRT-PCR data for a and c are represented as the mean ± s.d. of three independent replicates (P values: unpaired, two-sided Kolmogorov-Smirnov test).
one-third of MYC alleles are proximal to the nuclear periphery at any given time, the different alleles are probably in a constant flux. Despite our current ignorance of the principle (or principles) guiding the OSE-MYC complex to the nuclear pore, the most straightforward interpretation of our data is that the MYC alleles involved in the gating principle will be represented at any time by the population most proximal to the nuclear periphery or pore. If so, the efficiency of the nuclear mRNA export facilitated by the gating principle reported here is probably underestimated.
Interestingly, the RNA polymerase-complexed OSE establishes frequent interactions with a CTCF-binding site in the 5′-flank of MYC 47 . Such an arrangement could reflect a chromatin fiber communication enabling the OSE-mediated gating of MYC without necessarily invoking a concomitant transcriptional activation. Compounding this issue, MYC interacts equally with multiple active enhancers in both of its flanking TADs 31, 47 (Extended Data Fig. 2e,f) , some of which do not bind NUP153 (Fig. 1a,b , Extended Data Fig. 3b and Supplementary Table 1) 31 . This category includes the EnhD region, which showed increased potential for interaction with MYC only in intranucleoplasmic locations, indicating a partial division of labor among the enhancers regulating MYC expression. Given this scenario, one category of enhancers might primarily support transcriptional activation of MYC without direct connection to its gating, while the dynamic involvement of other enhancers, such as the OSE, might subsequently mediate the anchoring of transcriptionally active MYC alleles to the nuclear pore. As the OSE is part of an extensive virtual network of enhancers (Extended Data Fig. 3b ), it is possible that short and long-range 'cisvection' 48, 49 by the OSE temporally endows other enhancer regions with gating functions. Alternatively, the OSE transcriptionally activates MYC, but remains attached or reattaches to MYC when the gene approaches the nuclear pore during transcriptional termination. This interpretation concurs with a previously observed principle that a ribosomal RNA enhancer has been physically linked to transcriptional termination 50 .
We have also identified AHCTF1 as a key factor in the cancerspecific gating of MYC and shown that its recruitment to a TCF4binding site within the OSE is mediated by β-catenin. Although BC21 treatment did not affect the polarization of the OSE and MYC, it prevented the OSE from anchoring to the nuclear periphery or pore and decreased the export rate of mature MYC mRNAs. As BC21 did not affect MYC transcription, we conclude that it targets MYC expression post-transcriptionally by inhibiting the gating process. Given that TCF4-binding sites are distributed at many different positions in the MYC region inside and outside the OSE 29, 43 , the BC21 effect might conceivably depend on additional features at the OSE. For example, the TCF4-binding site examined here (WRE520) could collaborate with a CTCF-binding site in its immediate flank (Extended Data Fig. 7 ). This possibility concurs with our observation that CTCF can physically interact with both β-catenin and NUP133 (not shown). Importantly, BRD4 (ref. 29 ), a factor mediating the transcriptional effects of the OSE is not likely to be involved in the gating process. Thus, JQ1, an inhibitor of BRD4 (ref. 51 ), had no significant effect on the rate of nuclear export of MYC transcripts in HCT-116 cells (not shown), in line with the observation that HCT-116 cells are only moderately responsive to JQ1 (ref. 44 ). Although BRD4 is not functionally linked to the WNT pathway 44 , its association to the superenhancer overlaps with the TCF4-binding sites (Extended Data Fig. 8 ). Moreover, both mammalian BRD4 (ref. 29 ) and Drosophila ELYS 22 bind to chromatin regions enriched in the H3K27ac mark. The question then is whether AHCTF1, β-catenin and BRD4 binding to the super-enhancer can coexist on the same chromatin fiber, or whether they represent different adaptive choices to the microenvironments of the cell. Concurring with the latter scenario, resistance to the BRD4 inhibitor is associated with the activation of the WNT pathway to sustain MYC expression in acute myeloid leukemia 52 . As excessive MYC expression promotes WNT signaling in breast cancer 53 , a picture of complex feed-forward and feedback relationships between MYC and the WNT pathway emerges. Paradoxically, WNT3a administration to primary cultures of normal colon epithelial cells resulted in downregulation of MYC expression (Extended Data Fig. 9 ) without increasing the nuclear presence of β-catenin (not shown). Although WNT3a is generally considered to induce primarily canonical signaling, it has also been observed to trigger a non-canonical pathway 54 . The colon cancer cells might therefore have gained increased fitness from an acquired feature in their response to an external WNT ligand.
Our findings raise several questions. For example, can enhancermediated gene gating also take place in normal cells involving super-enhancers, such as those within the Igh locus 28 ? The observation that regions in the 5′-flank of Igh are responsible for its juxtaposition to the nuclear periphery or pore in mouse plasma cells expressing very high levels of cytoplasmic Igh transcripts 55 concurs with this possibility. By extrapolation, abnormal MYC expression in B cell lymphomas might result from a translocation of MYC into such a region. The accumulated data therefore converge on the possibility that transcriptional activation, amplification and WNT-βcatenin-regulated gene gating represent alternative routes for the pathological enhancement of MYC expression. Given the central role of WNT signaling in normal development and, specifically, that excessive WNT signaling maintains the self-renewal of cancer stem-like cells 56 , this novel link between TCF4-β-catenin and the gating of MYC might be of central importance. The ability of the MYC protein to influence mRNA CAP methylation of WNT target genes specifically 57 , its ability to reinforce the WNT signaling pathway 53, 58 and its link to the nuclear pore and gene expression 59 indicates different layers of possible feed-back regulation resulting from the β-catenin-dependent gating of MYC. Moreover, excessive WNT signaling is associated with high-risk neuroblastomas that do not display MYCN amplification 60 , raising the question of whether or not MYC paralogues are also gated. Related questions raise a potential link between gene gating and single-nucleotide polymorphisms (SNPs) predisposing to oncogenic transformation by enhancing or interdigitating environmental cues, such as the WNT signaling pathway 61 . Given the central role of MYC and its paralogues in cancer, targeting the cancer-cell-specific, WNT-regulated gating of MYC may hold new promises in cancer treatment.
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Methods
Cell culture. Human colon cancer cells (HCT-116), kindly provided by B. Vogelstein (Johns Hopkins Medical School and Sidney Kimmel Comprehensive Cancer Center), were maintained in McCoy's 5 A modified medium (Life Technologies, 16600-082) supplemented with 10% FBS, penicillin and streptomycin (Life Technologies). Primary cultures of normal colon epithelial cells (HCECs) were maintained in colonic epithelial cell medium (HCoEpiC, ScienCell, 2950). Both cells lines were cultured at 37 °C under 5% CO 2 and routinely screened for mycoplasma contamination using an EZ-PCR Mycoplasma Test Kit (Biological Industries, 20-700-20). HCT-116 cells were treated with 10 µM β-catenin and TCF Inhibitor V (BC21, Merck Millipore, 219334), or an equivalent amount of the solvent DMSO for 16 h. Recombinant human WNT3a (R&R Systems, 5036-WN) was reconstituted in PBS containing 0.1% BSA and added directly to the cell culture medium for the indicated lengths of time. Leptomycin B treatments of HCT-116 cells were performed as has been described previously 40 . siRNA transfection. Transfection of HCT-116 cells was performed as described 12 .
In brief, HCT-116 cells were transfected with 50 nM of AHCTF1 short interfering RNA (siRNA) (Santa Cruz, sc-77266), or GFP siRNA (Santa Cruz, sc-45924), by using Lipofectamine RNAiMAX transfection reagent (Life Technologies, 13778075) according to the manufacturer's instructions. Following 48 h of incubation, the cells were harvested and the siRNA-mediated downregulation of AHCTF1 was validated by qRT-PCR analysis.
Chromatin networks and integration analyses. The identification of chromatin networks impinging on MYC and flanking enhancers was done as previously described 31 . The baits used to generate the network are listed in Supplementary  Table 2 . For all integration analyses relevant to the Nodewalk networks, the 5 kb distance flanking each interactor was used throughout the manuscript as it approximates the average Hind III fragment size. Analyses were performed using the 'findOverlaps' function from the 'GRanges' R package. The cLADs were defined as genomic regions that were identified as LADs by a two-state hidden Markov model (HMM) 4 in both HESC and human HT1080 cells. Specifically, cLADs were defined as: LaminB1_hESC ∩ (LaminB1_hHT1080 ∪ LaminA_hHT1080). Closely located regions that were identified as LADs by the two-state HMM were merged together to form larger regions (Supplementary Table 1 ). The genomic coordinates were converted into the GRCh37.75 assembly using the UCSC liftOver tool (http:// genome-euro.ucsc.edu/cgi-bin/hgLiftOver). The HCT-116 super-enhancers flanking MYC were identified from dbSuper, a super-enhancer database 62 . Publicly available data for NUP153 binding were used (NUP153 DamID-seq peaks of U2OS cells were retrieved from Gene Expression Omnibus (GEO) with accession number GSE87831). Briefly, NUP153 DamID-seq peaks were identified by merging the replicate experiments and using the findPeaks program in HOMER v4.6 (ref. 6 ) with the GFP DamID-seq experiments as background. More detailed information can be found in the original publication 24 .
RNA FISH analyses.
The different RNA FISH probes were prepared as follows: the exon or intron probe was generated from a pool of four PCR products spanning the MYC promoter and its gene body (chr8:128,746,000-128,756,177 (GRCh37), Supplementary Table 3 ). The PCR products were sonicated and labeled with Biotin-16-dUTP (Roche, 11093070910) using a Bioprime Array CGH kit (Life Technologies, 18095-011). A mixture of equal amounts of each labeled PCR product was used as the FISH probe. The single-stranded intron 1 probe was prepared by generating double-stranded PCR fragments spanning MYC intron 1 (chr8:128,749,271-128,750,480), using a forward primer biotinylated at its 5′ terminal (Supplementary Table 3 ). The double-stranded, biotinylated DNA was labeled with green 496 dUTP (Enzo Life Sciences, ENZ-42381) using a Bioprime Array CGH kit and then captured by Dynabeads M280 streptavidin (Thermo Fisher Scientific, 11205D). The beads were incubated at 98 °C for 5 min to release and recover the non-biotinylated, labeled anti-sense strand. Finally, the singlestranded DNA was purified with Zymo Clean & Concentrator-5 (Zymo Research). RNA FISH analyses were performed as previously described 12 . Briefly, cells cultured on chamber slides (Thermo Fisher Scientific, 154534) were cross-linked with 3% formaldehyde for 15 min at room temperature (21 °C) and stored in 70% ethanol at −20 °C until use. The ribonuclease inhibitor ribonucleoside vanadyl complex (NEB, S1402S) was added to the buffers at all steps. Cells were rehydrated in 2× sodium salt citrate (SSC), and permeabilized with 0.5% Triton X-100 in 2× SSC for 10 min at room temperature. The FISH probe was mixed with a tenfold excess of human Cot-1 DNA (Invitrogen, 15279-011) and hybridized to the slides in a buffer containing 2× SSC, 50% formamide and 10% dextran sulfate overnight at 37 °C. Cells were washed twice with 2× SSC in 50% formamide for 15 min at 40 °C and with 2× SSC for 15 min at 40 °C, followed by mounting with Vectashield mounting medium containing 4,6-diamidino-2-phenylindole (DAPI) (Vector Labs, H-1200).
DNA FISH analyses.
The DNA FISH probes were prepared from a pool of PCR products spanning 8-10 kb regions of Hind III sites encompassing the MYC promoter and gene body (chr8:128,746,000-128,756,177), the OSE (positioned at chr8:128,216,526-128,225,855), or an in-between enhancer (EnhD, positioned at chr8:128413009-128414109) 38 , respectively. The probes were generated by PCR amplification using primers labeled with green 496 dUTP (Enzo, 42831) or Cy3-dCTP (GE Healthcare, PA53031; Supplementary Table 3 ). To visualize the genomic regions surrounding the OSE and MYC loci we used the bacterical artificial chromosome (BAC) clone CTD-3066D1. DNA FISH analyses were performed as previously described 12 . In brief, cells were cross-linked and permeabilized as described for RNA FISH. After denaturation in 2× SSC in 50% formamide for 40 min at 80 °C, cells were kept in ice cold 2× SSC for 5 min. The FISH probe was mixed with a tenfold excess of human Cot-1 DNA (Invitrogen, 15279-011) and hybridized to the slides in a buffer containing 2× SSC, 50% formamide and 10% dextran sulfate overnight at 37 °C. The cells were then washed twice with 2× SSC in 50% formamide for 15 min at 40 °C, followed by a wash with 2× SSC for 15 min at 42 °C and with 0.1× SSC for 30 min at 60 °C. Finally, the cells were mounted in Vectashield mounting medium containing DAPI (Vector Labs, H-1200).
ChrISP analyses. The DNA FISH probes complementary to the MYC promoter or gene body, or the OSE were labeled with DIG-11-dUTP (Roche, 11573152910) as described in the RNA FISH protocol above. For the proximity analysis between the DIG-labeled probes hybridizing to either the MYC promoter or gene body or the OSE and the nuclear pore component NUP133, a tyramide signal amplification step (TSA kit with biotin-XX tyramide, Life Technologies, T-20921) was included to increase the concentration of biotin molecules in the vicinity of the NUP133 epitopes. The TSA reaction was performed as described in the manufacturer's protocol. In brief, after hybridization of the FISH probes and incubation with the primary antibodies anti-NUP133 (Abcam, ab155990) and anti-DIG (Roche, 11333062910) overnight at 4 °C, cells were washed with 0.05% Tween 20 in PBS and blocked for 1 h at room temperature, followed by an incubation with anti-horse radish peroxidase (HRP) for 1 h at room temperature. After a further washing step in PBS, cells were treated with the TSA-working solution for 5 min, washed again with PBS and incubated with anti-biotin antibody (Abcam, ab53494) overnight at 4 °C. After an overnight washing step in 0.1× SSC at 37 °C, the ChrISP assay was performed and quantitated as previously described 2 . As a technical, negative control of the ChrISP assay, a sample omitting the mouse secondary ChrISP antibody was included in parallel, called R plus control, in each experiment. Falsepositive signals (FPSs) of less than 0.05 were defined as the proportion of ChrISP signal of the technical negative control (experiment without one of the secondary antibodies) emerging above baseline. To distinguish the technical noise from experimental variation, we subtracted the intensity corresponding to FPS less than 0.05 from the intensity of each ChrISP signal in the samples.
Signal intensities less than 0 were rounded to 0, as indicated in the figures, unless otherwise stated or shown. The proximity between the MYC promoter or gene body and the OSE was analyzed as described by Sumida et al. 31 .
ISPLAs. The ISPLAs were performed on formaldehyde-fixed cells and quantitated as has been described previously 12 . For the β-catenin-TCF4 ISPLA we used a mouse monoclonal anti-β-catenin (Santa Cruz, sc-7963) and rabbit polyclonal anti-TCF4 (Abcam, ab185736), whereas the β-catenin-AHCTF1 ISPLA used a mouse monoclonal anti-β-catenin (Santa Cruz, sc-7963) and rabbit polyclonal AHCTF1 (Novus Biologicals, NBP1-87952). Finally, a mouse monoclonal TCF4 (Santa Cruz, sc-166699) was used in combination with the rabbit AHCTF1 antibody for the TCF4-AHCTF1 ISPLA. Modified antibodies (termed R+ and M−) were added to the slides after incubation with primary antibodies, followed by rolling circle amplification, as has been described previously 12 . Samples that lacked the primary antibodies served as background controls 2 .
Grid wide-field microscopy. Cell imaging and the generation of optical sections in 3D were carried out on a Leica DMI 3000B fluorescent microscope (Leica) with an OptiGrid device (Grid Confocal) using Volocity software (Quorum Technologies). Stacks were taken at 0.3 μm intervals in the z axis. On average, 150-300 alleles were counted for distance measurements or ChrISP and ISPLA signal intensity in each case. RNA FISH signals were determined by subtracting the intensity of the background in the immediate surroundings.
Link original microscopic images: https://doi.org/10.1038/s41588-019-0535-3
Pulse labeling of RNA. Newly synthesized RNA was generated by incubating the cells with 0.5 mM (final concentration) 5′-ethynyl uridine (Thermo Fisher Scientific, E10345) for 15 or 30 min, as indicated in the text. For pulse-chase, cells were washed with 5× PBS after the labeling with 5′-ethynyl uridine and then incubated with pre-warmed normal growing medium for the indicated periods. The separation of the nuclear and cytoplasmic fraction and the RNA isolation was performed by using the Ambion PARIS system (Thermo Fisher Scientific, AM1921) according to the manufacturer's protocol. Briefly, 300 μl of fractionation buffer was used to lyse the cells. The nuclear and cytoplasmic fractions were separated following centrifugation at 500 g for 5 min. Labeled RNA or total RNA were purified with the RNeasy Mini kit (Qiagen, 74014). 5′-ethynyl uridinelabeled RNAs were captured using a Click-iT nascent RNA capture kit (Thermo Fisher Scientific, C10365) following the manufacturer's instructions before their conversion into cDNA using a SuperScript VILO cDNA synthesis kit (Life Technologies, 11754050). Fig. 1 | The Nodewalk principle and associated quality controls. a) Schematic representation of the Nodewalk procedure (see also 31 ). Region of interest (Bait: blue) and an interacting locus (Interactor: green) are represented with lines depicting the restriction site (Hind III). Horizontal arrows indicate primers. b) Schematic representation of oligo DNAs and primers designed for the Nodewalk protocol. c) Principle to generate cDNAs from 3 C RNA. d) Assay to evaluate the fold enrichment of specifically primed 3 C cDNAs. The DNA band indicated by an arrow represents the enriched bait fragment. These experiments were repeated more than 20 times with similar results. Panel e) shows the recovery of interactors between two independent replicates while f) shows the amounts of reproducible interactors between two independent replicates stratified as indicated in the panel (see also Supplementary Table 1 ). g) Accumulated reproducibility between two independent experiments. h) Map of the MYC locus with arrows indicating the position of interactors identified by using MYC as initial bait. See reference 31 for further information. Also shown are the NUP153 DamID-seq peaks of U2OS cells, publicly available from GEO (accession number GSE87831) 24 All baits were selected from the interactors of MYC that were included in the flanking TADs on chromosome 8, except for bait nr 10 that originated from chromosome 5 ( Supplementary Table 2 ). Vertical lines indicate the interactors and their ligation events (LE) impinging on MYC. d) The network structure from HCT116 cells stratified by its k-core values. The red and green nodes identify regions overlapping with H3K27ac and H3K4me1 peaks, respectively. The size of each node reflects the number of detected interactions. e) Distribution of interactors generated from enhancer baits from within TAD 1 and 2, respectively. f) The interactions of enhancer hubs largely follow the TAD boundaries -with the exception for the MYC bait (nr 5), which interacts with regions equally distributed within both flanking TADs in both HCEC and HCT116 cells. Fig. 3 | The link between chromatin networks, enhancers and NuP153 in HCT-116 cells. a) Schematic view of the genomic position of the Nodewalk baits (arrow heads). Nodewalk is a 3C-based technique that is based on the conversion of ligated chromatin DNA fragments into chimeric RNA sequences followed by cDNA priming using strategically positioned primers (baits) close to either end of key Hind III fragments listed in Supplementary  Table 2 31 . The ligation events (LEs) in A) indicate the frequency of interactions between MYC and its neighbouring regions. With the exception of its most immediate neighbourhood, by far the most prominent region to contact MYC is represented by the distal super-enhancer depicted by the b and c baits. b) Enhancer hubs with or without NUP153 binding sites (NUP153-positive or negative, respectively) were numbered and colour-coded as indicated in (a) and in the images. The larger circles represent baits (indicated by letters in (a)), while the smaller circles represent interactors detected by these baits and which are connected to 3 or more nodes in the network (K core > 3). c) The extent to which the enhancer baits are connected to one another positively correlates with NUP153 binding sites positioned within 5 kb from the point of interaction (left image; p = 4.68E-06), but not with location within constitutive lamina-associated domains (cLADs) (right image; p = 1.2E-05). The Y axes show the % of interactors with or without NUP153 binding sites or a genomic position inside or outside constitutive LADs (cLADs), while the X axes show the number of connections an enhancer bait has to other enhancer baits. The data is based on 9 independent Nodewalk analyses (See Supplementary Table 1 for additional information). P values: two-sided Fisher's exact test. d) Interpretation (viewed from the nuclear side) of data in panel c. Fig. 4 | Schematic illustration of the ChrISP technique using the fluorescently labelled splinter approach to score for chromatin fibre proximities. The method is based on aptamer-conjugated secondary antibodies against primary rabbit or mouse antibodies, targeting either biotin-and digoxygenin-labelled DNA FISH probes, or against a protein epitope and a biotin-labelled DNA FISH probe. The fluorescently labelled splinter (in green) will anneal to the aptamers of the secondary antibodies only if the epitopes they recognise are within 162 Å from each other. The annealing step is subsequently stabilised by the ligation of a backbone DNA (in black) 35, 36 . The in situ proximity ligation assays were performed using mouse anti-ß-catenin and rabbit anti-AHCTF1 antibodies followed by staining with oligo-DNA modified secondary antibodies and ligation of splinter oligo DNA 12 . The physical proximity between TCF4 and AHCTF1 is subsequently detected by rolling circle amplifications. The amplification products were detected using a labelled oligo detector DNA to generate bright yellow dots. The nuclei were counterstained with DAPI. The experiments were repeated on two independent occasions with similar results. Bar = 10 μm. See Fig. 5a for a quantitation of the ISPLA signals in control (DMSO ctrl) and BC21-treated cells.
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